tiprankstipranks
Advertisement
Advertisement

RYTM Stock Latest News

Rhythm Pharmaceuticals Signals Momentum Despite Rising Costs
Company AnnouncementsRhythm Pharmaceuticals Signals Momentum Despite Rising Costs
3d ago
RYTM
Aardvark Therapeutics downgraded to Underperform from Buy at BofA
PremiumThe Fly
Aardvark Therapeutics downgraded to Underperform from Buy at BofA
8d ago
AARD
NBIX
Palatin Is Betting on the Next Generation of Obesity Drugs (NYSE: PTN)
PremiumTipRanks Newswire
Palatin Is Betting on the Next Generation of Obesity Drugs (NYSE: PTN)
10d ago
NVO
PTN
Buy Rating Reiterated as IMCIVREE Adoption Outpaces Expectations; $105 Price Target Maintained
PremiumRatings
Buy Rating Reiterated as IMCIVREE Adoption Outpaces Expectations; $105 Price Target Maintained
12d ago
RYTM
Rhythm Pharmaceuticals price target raised to $143 from $140 at Canaccord
PremiumThe Fly
Rhythm Pharmaceuticals price target raised to $143 from $140 at Canaccord
16d ago
RYTM
Rhythm Pharmaceuticals Bets Big On Obesity Growth
PremiumCompany AnnouncementsRhythm Pharmaceuticals Bets Big On Obesity Growth
17d ago
RYTM
Rhythm Pharmaceuticals reports Q1 EPS (83c), consensus (86c)
Premium
The Fly
Rhythm Pharmaceuticals reports Q1 EPS (83c), consensus (86c)
18d ago
RYTM
Rhythm Pharmaceuticals sees FY26 operating expenses $385M-$415M
Premium
The Fly
Rhythm Pharmaceuticals sees FY26 operating expenses $385M-$415M
18d ago
RYTM
Rhythm Pharmaceuticals presents Phase 3 TRANSCEND trial data
PremiumThe Fly
Rhythm Pharmaceuticals presents Phase 3 TRANSCEND trial data
19d ago
RYTM
RYTM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
RYTM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
20d ago
RYTM
Rhythm Pharmaceuticals’ Imcivree granted MAA in Europe for obesity
PremiumThe Fly
Rhythm Pharmaceuticals’ Imcivree granted MAA in Europe for obesity
22d ago
RYTM
Rhythm Pharmaceuticals price target raised to $136 from $130 at RBC Capital
PremiumThe Fly
Rhythm Pharmaceuticals price target raised to $136 from $130 at RBC Capital
2M ago
RYTM
Rhythm Pharmaceuticals appoints Popovits to board of directors
PremiumThe FlyRhythm Pharmaceuticals appoints Popovits to board of directors
2M ago
RYTM
Rhythm Pharmaceuticals Gains EMA Backing for IMCIVREE Expansion
Premium
Company Announcements
Rhythm Pharmaceuticals Gains EMA Backing for IMCIVREE Expansion
2M ago
8K
RYTM
Rhythm Pharmaceuticals price target raised to $105 from $100 at H.C. Wainwright
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $105 from $100 at H.C. Wainwright
2M ago
RYTM
Rhythm Pharmaceuticals selects Pantherx Rare as pharmacy for Imcivree
PremiumThe Fly
Rhythm Pharmaceuticals selects Pantherx Rare as pharmacy for Imcivree
2M ago
RYTM
Rhythm Wins FDA Nod for Hypothalamic Obesity Therapy
PremiumCompany Announcements
Rhythm Wins FDA Nod for Hypothalamic Obesity Therapy
2M ago
8K
RYTM
Rhythm Pharmaceuticals price target raised to $149 from $139 at BofA
PremiumThe Fly
Rhythm Pharmaceuticals price target raised to $149 from $139 at BofA
2M ago
RYTM
Palatin’s Case Strengthens as Rhythm’s FDA Approval Validates Hypothalamic Obesity Market (PTN)
PremiumTipRanks Newswire
Palatin’s Case Strengthens as Rhythm’s FDA Approval Validates Hypothalamic Obesity Market (PTN)
2M ago
PTN
RYTM
Rhythm Pharmaceuticals price target raised to $142 from $131 at Citi
PremiumThe FlyRhythm Pharmaceuticals price target raised to $142 from $131 at Citi
2M ago
RYTM
Rhythm Pharmaceuticals price target raised to $155 from $152 at Citizens
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $155 from $152 at Citizens
2M ago
RYTM
Rhythm Pharmaceuticals trading resumes
Premium
The Fly
Rhythm Pharmaceuticals trading resumes
2M ago
RYTM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >